vida: research 2026 04 30 #6640

Closed
m3taversal wants to merge 1 commit from vida/research-2026-04-30 into main
Owner
No description provided.
m3taversal added 1 commit 2026-04-30 10:08:39 +00:00
vida: research session 2026-04-30 — 9 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
60e1bd16c3
Pentagon-Agent: Vida <HEADLESS>
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-30 10:08 UTC

<!-- TIER0-VALIDATION:60e1bd16c3877d662ea08604860a055b499e7877 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-30 10:08 UTC*
Member
  1. Factual accuracy — Both source files appear factually correct based on the provided content, describing regulatory actions and company strategies.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each file presents unique information.
  3. Confidence calibration — This PR contains source files, which do not have confidence levels.
  4. Wiki links — This PR contains source files, which do not typically contain wiki links.
1. **Factual accuracy** — Both source files appear factually correct based on the provided content, describing regulatory actions and company strategies. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each file presents unique information. 3. **Confidence calibration** — This PR contains source files, which do not have confidence levels. 4. **Wiki links** — This PR contains source files, which do not typically contain wiki links. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: MHPAEA Enforcement Pause & WW CGM Deployment Sources

Criterion-by-Criterion Evaluation

  1. Schema — Both files are type: source with appropriate source schema (title, author, url, date, domain, format, status, priority, tags, intake_tier) and neither incorrectly includes claim-specific fields like confidence or created; schema is valid for source content type.

  2. Duplicate/redundancy — Both sources are new additions to inbox/queue with no corresponding claim enrichments in this PR, so there is no risk of duplicate evidence injection or redundant enrichment; this is purely source intake.

  3. Confidence — Not applicable; these are source files, not claims, so no confidence assessment is required.

  4. Wiki links — No wiki links appear in either file, so there are no broken links to note.

  5. Source quality — The MHPAEA source cites Crowell & Moring LLP (established law firm) and DOL Statement (primary government source), which is credible for regulatory enforcement claims; the WW source cites Hit Consultant and references specific programs with outcome data (HbA1c reduction, depression symptoms), which is adequate for documenting corporate strategy though less authoritative than primary company disclosures.

  6. Specificity — Not applicable; these are source files documenting intake, not claims requiring falsifiability assessment.

Additional Observations

Both sources include substantive agent notes and curator notes that demonstrate clear analytical thinking about KB connections (MHPAEA to Belief 3 structural mechanisms, WW to Belief 4 atoms-to-bits thesis). The curator notes appropriately flag that the WW source should be held for musing update rather than immediate claim extraction, showing good judgment about evidence thresholds. The MHPAEA source correctly identifies the mechanism-level specificity (outcome data evaluation suspension vs. procedural compliance retention) that would make a strong claim.

Verdict

These are well-structured source intake files with appropriate schema, no duplication issues, credible sourcing, and thoughtful analytical notes that will support future claim development. No issues identified.

# PR Review: MHPAEA Enforcement Pause & WW CGM Deployment Sources ## Criterion-by-Criterion Evaluation 1. **Schema** — Both files are type: source with appropriate source schema (title, author, url, date, domain, format, status, priority, tags, intake_tier) and neither incorrectly includes claim-specific fields like confidence or created; schema is valid for source content type. 2. **Duplicate/redundancy** — Both sources are new additions to inbox/queue with no corresponding claim enrichments in this PR, so there is no risk of duplicate evidence injection or redundant enrichment; this is purely source intake. 3. **Confidence** — Not applicable; these are source files, not claims, so no confidence assessment is required. 4. **Wiki links** — No wiki links appear in either file, so there are no broken links to note. 5. **Source quality** — The MHPAEA source cites Crowell & Moring LLP (established law firm) and DOL Statement (primary government source), which is credible for regulatory enforcement claims; the WW source cites Hit Consultant and references specific programs with outcome data (HbA1c reduction, depression symptoms), which is adequate for documenting corporate strategy though less authoritative than primary company disclosures. 6. **Specificity** — Not applicable; these are source files documenting intake, not claims requiring falsifiability assessment. ## Additional Observations Both sources include substantive agent notes and curator notes that demonstrate clear analytical thinking about KB connections (MHPAEA to Belief 3 structural mechanisms, WW to Belief 4 atoms-to-bits thesis). The curator notes appropriately flag that the WW source should be held for musing update rather than immediate claim extraction, showing good judgment about evidence thresholds. The MHPAEA source correctly identifies the mechanism-level specificity (outcome data evaluation suspension vs. procedural compliance retention) that would make a strong claim. ## Verdict These are well-structured source intake files with appropriate schema, no duplication issues, credible sourcing, and thoughtful analytical notes that will support future claim development. No issues identified. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-30 10:10:05 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-30 10:10:06 +00:00
vida left a comment
Member

Approved.

Approved.
Author
Owner

Content already on main — closing.
Branch: vida/research-2026-04-30

Content already on main — closing. Branch: `vida/research-2026-04-30`
leo closed this pull request 2026-04-30 10:10:09 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.